- Par Pharm., Inc. v. Eagle Pharms., Inc.
- Vifor Fresenius Medical Care Renal Pharma Ltd. v. Teva Pharms. USA, Inc.
- President Signs Wide-Ranging Inflation Reduction Act into Law
- Briefly: Line Dancing for Lawyers, Take 2
- Third Point Takes Stake in Disney, Pushes for ESPN Spinoff
- Chiesi USA, Inc. v. Aurobindo Pharma USA, Inc.
- Tris Pharma, Inc. v. Teva Pharms. USA, Inc.,
- Rivian, Facing Supply-Chain Woes, Posts Massive $1.7B Quarterly Loss
- CPI Report Shows Slowing Inflation, Boosts Markets
- Crypto Crash Takes $1B Bite Out of Coinbase in Q2
- Salix Pharms., Ltd. v. Norwich Pharms., Inc.
- SoftBank Hit With $20+ Billion Quarterly Loss as Tech Investments Falter
- All Eyes on July Jobs Report Following Fed Rate Hikes
- Walmart to Cut 200 Corporate Positions Following Lowered Profit Forecasts
- Robinhood Cuts Workforce by 23% to Counter Ill-Advised Expansion
- Opendoor to Pay $62 Million to Settle FTC Claims That It Misled Homeowners
- August 1, 2022Why Directors Need To Talk About Insolvency
- Fed Again Raises Rates 75 bps in Bid to Tame Inflation
- IMF Revises Outlook for Global Growth, Warns of Looming Recession
- Feds Propose $85M Settlement With Chicken Producers Over Alleged Harm to Workers
- Second QuarterANDA Approvals
- Second QuarterGeneric Launches
- Amazon Pushes Further Into Health Sector With $3.9B One Medical Acquisition
- ECB Set to Raise Interest Rates for First Time In 10 Years to Fight Eurozone Inflation
- Netflix Loses 1M Subscribers But Preaches Recovery
- Briefly: What to do with a Reverse and Remand
- Goldman Sachs Beats Expectations as Big Bank Earning Seasons Rolls Along
- Feds Fine Bank of America $225M for Mistakenly Freezing Pandemic Relief Funds
- June Inflation Booms, Confirming Another Big Fed Rate Hike
- Twitter Sues Musk in Delaware Chancery Court to Force Acquisition
- Elon Ditches Twitter Deal; High-Stakes Litigation Expected
- AstraZeneca AB v. Mylan Pharms., Inc.
- Second QuarterANDA Litigation Settlements
- Second QuarterNew ANDA Cases
- July 8, 2022Sanofi-Aventis U.S. LLC v. Apotex Corp.
- Markets Close Out Worst First-Half Performance in 50 Years
- Spirit Again Delays Shareholder Vote on Frontier Deal After JetBlue Sweetens Bid
- Despite Headwinds, Disney Reappoints Chapek as CEO Through 2025
- July 2022Be Warned: As Fiduciary Duties Shift, So, Too, Can Privilege Ownership
- July 2022The ABCs of PBCs: How This Relatively New Corporate Form Mandates a Broader View of Business
- EY to Pay Record Fine to SEC Over Cheating on Ethics Test
- July 2022We Don’t Talk About Insolvency (No, No, No …)
- Biggest US Banks Sail Through Latest Round of Fed Stress Testing
- Powell Admits Recession Possible, Sees Tricky Path to Soft Landing
- Meta Reaches Settlement With Feds Over Allegedly Discriminatory Housing Ads
- Briefly: How To Oppose An Extension If You Really Need To
- June 21, 2022Novartis Pharms. Corp. v. Accord Healthcare, Inc.
- Markets Tank Again As Recession Fears Join Inflation Worries
- Fed Gets Bold, Raises Rates .75% In Bid to Tame Inflation
- U.S. LNG Prices Plummet After Texas Fire Cuts Export Capacity
